Comments
Loading...
Cardinal Health Analyst Ratings and Price Targets | NYSE:CAH | Benzinga
Cardinal Health Inc has a consensus price target of $119.24 based on the ratings of 21 analysts. The high is $150 issued by Jefferies on February 5, 2025. The low is $64 issued by Barclays on May 26, 2022. The 3 most-recent analyst ratings were released by Jefferies, JP Morgan, and Wells Fargo on February 5, 2025, February 4, 2025, and February 4, 2025, respectively. With an average price target of $143.67 between Jefferies, JP Morgan, and Wells Fargo, there's an implied 7.68% upside for Cardinal Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Jefferies
JP Morgan
Wells Fargo
Morgan Stanley
Citigroup
1calculated from analyst ratings
Analyst Ratings for Cardinal Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/05/2025 | Buy Now | 12.43% | Jefferies | Brian Tanquilut45% | $140 → $150 | Upgrade | Hold → Buy | Get Alert |
| 02/04/2025 | Buy Now | 8.68% | JP Morgan | Lisa Gill59% | $142 → $145 | Maintains | Neutral | Get Alert |
| 02/04/2025 | Buy Now | 1.94% | Wells Fargo | Stephen Baxter54% | $135 → $136 | Maintains | Equal-Weight | Get Alert |
| 01/31/2025 | Buy Now | 6.43% | Morgan Stanley | Erin Wright75% | $136 → $142 | Maintains | Overweight | Get Alert |
| 01/29/2025 | Buy Now | 1.19% | Wells Fargo | Stephen Baxter54% | $127 → $135 | Maintains | Equal-Weight | Get Alert |
| 01/24/2025 | Buy Now | 6.43% | JP Morgan | Lisa Gill59% | $132 → $142 | Maintains | Neutral | Get Alert |
| 01/10/2025 | Buy Now | -3.31% | Citigroup | Daniel Grosslight43% | $120 → $129 | Maintains | Neutral | Get Alert |
| 01/08/2025 | Buy Now | 7.93% | TD Cowen | Charles Rhyee37% | $130 → $144 | Upgrade | Hold → Buy | Get Alert |
| 01/07/2025 | Buy Now | 4.94% | Evercore ISI Group | Elizabeth Anderson47% | $140 → $140 | Upgrade | In-Line → Outperform | Get Alert |
| 01/06/2025 | Buy Now | 8.68% | B of A Securities | Michael Cherny79% | $132 → $145 | Upgrade | Neutral → Buy | Get Alert |
| 12/17/2024 | Buy Now | 1.94% | Morgan Stanley | Erin Wright75% | $127 → $136 | Maintains | Overweight | Get Alert |
| 12/13/2024 | Buy Now | -4.81% | Wells Fargo | Stephen Baxter54% | $101 → $127 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/04/2024 | Buy Now | -4.81% | Morgan Stanley | Erin Wright75% | $119 → $127 | Maintains | Overweight | Get Alert |
| 11/04/2024 | Buy Now | -7.06% | Deutsche Bank | George Hill62% | $119 → $124 | Maintains | Hold | Get Alert |
| 11/04/2024 | Buy Now | 4.19% | UBS | Kevin Caliendo72% | $134 → $139 | Maintains | Buy | Get Alert |
| 11/04/2024 | Buy Now | -10.06% | Mizuho | Ann Hynes86% | $110 → $120 | Maintains | Neutral | Get Alert |
| 11/04/2024 | Buy Now | -0.31% | Barclays | Stephanie Davis40% | $117 → $133 | Maintains | Overweight | Get Alert |
| 10/22/2024 | Buy Now | 0.44% | UBS | Kevin Caliendo72% | $125 → $134 | Maintains | Buy | Get Alert |
| 09/11/2024 | Buy Now | -6.31% | Argus Research | David Toung72% | $115 → $125 | Maintains | Buy | Get Alert |
| 08/21/2024 | Buy Now | -7.81% | JP Morgan | Lisa Gill59% | $111 → $123 | Maintains | Neutral | Get Alert |
| 08/16/2024 | Buy Now | -10.8% | Deutsche Bank | George Hill62% | $115 → $119 | Maintains | Hold | Get Alert |
| 08/15/2024 | Buy Now | -6.31% | UBS | Kevin Caliendo72% | $120 → $125 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | -24.3% | Wells Fargo | Stephen Baxter54% | $95 → $101 | Maintains | Underweight | Get Alert |
| 08/15/2024 | Buy Now | -10.8% | Morgan Stanley | Erin Wright75% | $114 → $119 | Maintains | Overweight | Get Alert |
| 08/15/2024 | Buy Now | -13.8% | Evercore ISI Group | Elizabeth Anderson47% | $105 → $115 | Maintains | In-Line | Get Alert |
| 08/15/2024 | Buy Now | 2.69% | Baird | Eric Coldwell80% | $130 → $137 | Maintains | Outperform | Get Alert |
| 07/19/2024 | Buy Now | -19.8% | Citigroup | Daniel Grosslight43% | $115 → $107 | Maintains | Neutral | Get Alert |
| 07/09/2024 | Buy Now | -21.3% | Evercore ISI Group | Elizabeth Anderson47% | $115 → $105 | Maintains | In-Line | Get Alert |
| 07/09/2024 | Buy Now | -2.56% | Baird | Eric Coldwell80% | $129 → $130 | Maintains | Outperform | Get Alert |
| 05/15/2024 | Buy Now | -13.8% | Argus Research | David Toung72% | $120 → $115 | Maintains | Buy | Get Alert |
| 05/06/2024 | Buy Now | -17.55% | Deutsche Bank | George Hill62% | $116 → $110 | Maintains | Hold | Get Alert |
| 05/03/2024 | Buy Now | -13.8% | Evercore ISI Group | Elizabeth Anderson47% | $110 → $115 | Maintains | In-Line | Get Alert |
| 05/03/2024 | Buy Now | -4.06% | Baird | Eric Coldwell80% | $134 → $128 | Maintains | Outperform | Get Alert |
| 04/29/2024 | Buy Now | -29.54% | Wells Fargo | Stephen Baxter54% | $96 → $94 | Maintains | Underweight | Get Alert |
| 02/26/2024 | Buy Now | -6.31% | Leerink Partners | Michael Cherny79% | → $125 | Initiates | → Outperform | Get Alert |
| 02/09/2024 | Buy Now | — | Argus Research | David Toung72% | — | Upgrade | Hold → Buy | Get Alert |
| 02/05/2024 | Buy Now | -6.31% | UBS | Kevin Caliendo72% | $122 → $125 | Maintains | Buy | Get Alert |
| 01/29/2024 | Buy Now | -8.56% | UBS | Kevin Caliendo72% | $114 → $122 | Maintains | Buy | Get Alert |
| 01/03/2024 | Buy Now | -12.3% | Barclays | Stephanie Davis40% | → $117 | Initiates | → Overweight | Get Alert |
| 12/14/2023 | Buy Now | -28.04% | Wells Fargo | Stephen Baxter54% | → $96 | Initiates | → Underweight | Get Alert |
| 11/17/2023 | Buy Now | -16.05% | JP Morgan | Lisa Gill59% | $101 → $112 | Maintains | Neutral | Get Alert |
| 11/09/2023 | Buy Now | -21.3% | Deutsche Bank | George Hill62% | $102 → $105 | Maintains | Hold | Get Alert |
| 11/06/2023 | Buy Now | -22.05% | Mizuho | Ann Hynes86% | $95 → $104 | Maintains | Neutral | Get Alert |
| 08/17/2023 | Buy Now | -23.55% | Deutsche Bank | George Hill62% | $90 → $102 | Maintains | Hold | Get Alert |
| 08/16/2023 | Buy Now | -32.54% | TD Cowen | Charles Rhyee37% | $88 → $90 | Maintains | Market Perform | Get Alert |
| 08/16/2023 | Buy Now | -24.3% | JP Morgan | Lisa Gill59% | $93 → $101 | Maintains | Neutral | Get Alert |
| 08/16/2023 | Buy Now | -25.05% | Morgan Stanley | Erin Wright75% | $92 → $100 | Maintains | Overweight | Get Alert |
| 08/16/2023 | Buy Now | -19.05% | Baird | Eric Coldwell80% | $107 → $108 | Maintains | Outperform | Get Alert |
| 08/16/2023 | Buy Now | -28.04% | Mizuho | Ann Hynes86% | $94 → $96 | Maintains | Neutral | Get Alert |
| 07/11/2023 | Buy Now | -29.54% | Mizuho | Ann Hynes86% | $85 → $94 | Maintains | Neutral | Get Alert |
| 07/10/2023 | Buy Now | -25.05% | Evercore ISI Group | Elizabeth Anderson47% | → $100 | Downgrade | Outperform → In-Line | Get Alert |
| 06/12/2023 | Buy Now | -32.54% | Citigroup | Daniel Grosslight43% | $88 → $90 | Maintains | Neutral | Get Alert |
| 06/12/2023 | Buy Now | -36.29% | Barclays | Steven Valiquette58% | $80 → $85 | Maintains | Equal-Weight | Get Alert |
| 06/12/2023 | Buy Now | -25.05% | Credit Suisse | Jonathan Yong64% | $90 → $100 | Maintains | Neutral | Get Alert |
| 06/12/2023 | Buy Now | -27.29% | UBS | Kevin Caliendo72% | $93 → $97 | Maintains | Buy | Get Alert |
| 06/09/2023 | Buy Now | -30.29% | JP Morgan | Lisa Gill59% | $90 → $93 | Maintains | Neutral | Get Alert |
| 05/08/2023 | Buy Now | -34.04% | Citigroup | Daniel Grosslight43% | $77 → $88 | Maintains | Neutral | Get Alert |
| 05/08/2023 | Buy Now | -32.54% | Deutsche Bank | George Hill62% | $88 → $90 | Maintains | Hold | Get Alert |
| 05/05/2023 | Buy Now | -34.04% | Barclays | Steven Valiquette58% | $77 → $88 | Maintains | Equal-Weight | Get Alert |
| 04/26/2023 | Buy Now | -34.04% | Deutsche Bank | George Hill62% | $77 → $88 | Maintains | Hold | Get Alert |
| 03/31/2023 | Buy Now | -42.29% | Citigroup | Daniel Grosslight43% | → $77 | Initiates | → Neutral | Get Alert |
| 03/22/2023 | Buy Now | -42.29% | Deutsche Bank | George Hill62% | $82 → $77 | Maintains | Hold | Get Alert |
| 02/03/2023 | Buy Now | -31.04% | Credit Suisse | Jonathan Yong64% | $89 → $92 | Maintains | Neutral | Get Alert |
| 02/03/2023 | Buy Now | -32.54% | Morgan Stanley | Erin Wright75% | $86 → $90 | Maintains | Overweight | Get Alert |
| 02/03/2023 | Buy Now | -29.54% | Baird | Eric Coldwell80% | $87 → $94 | Upgrade | Neutral → Outperform | Get Alert |
| 01/31/2023 | Buy Now | -31.79% | UBS | Kevin Caliendo72% | $78 → $91 | Maintains | Buy | Get Alert |
| 01/06/2023 | Buy Now | -35.54% | Morgan Stanley | Erin Wright75% | $82 → $86 | Maintains | Overweight | Get Alert |
| 11/22/2022 | Buy Now | -40.79% | Credit Suisse | A.J. Rice68% | $64 → $79 | Maintains | Neutral | Get Alert |
| 11/14/2022 | Buy Now | -44.53% | Mizuho | Ann Hynes86% | $66 → $74 | Maintains | Neutral | Get Alert |
| 11/07/2022 | Buy Now | -38.54% | Morgan Stanley | Erin Wright75% | $76 → $82 | Maintains | Overweight | Get Alert |
| 11/07/2022 | Buy Now | -38.54% | Baird | Eric Coldwell80% | $74 → $82 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | -40.04% | B of A Securities | Michael Cherny79% | $64 → $80 | Upgrade | Underperform → Neutral | Get Alert |
| 08/29/2022 | Buy Now | -41.54% | UBS | Kevin Caliendo72% | $61 → $78 | Maintains | Buy | Get Alert |
| 08/22/2022 | Buy Now | -43.03% | Morgan Stanley | Erin Wright75% | $70 → $76 | Maintains | Overweight | Get Alert |
| 08/16/2022 | Buy Now | -46.03% | Cowen & Co. | Charles Ryhee50% | $59 → $72 | Maintains | Market Perform | Get Alert |
| 08/12/2022 | Buy Now | -52.03% | Credit Suisse | A.J. Rice68% | $56 → $64 | Maintains | Neutral | Get Alert |
| 08/12/2022 | Buy Now | -45.28% | Baird | Eric Coldwell80% | $57 → $73 | Maintains | Neutral | Get Alert |
| 07/14/2022 | Buy Now | -47.53% | Morgan Stanley | Ricky Goldwasser78% | $74 → $70 | Maintains | Overweight | Get Alert |
| 05/26/2022 | Buy Now | -52.03% | Barclays | Steve Valiquette53% | $70 → $64 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/18/2022 | Buy Now | -49.03% | Evercore ISI Group | Elizabeth Anderson47% | → $68 | Upgrade | In-Line → Outperform | Get Alert |
| 05/06/2022 | Buy Now | -58.03% | Credit Suisse | A.J. Rice68% | $58 → $56 | Maintains | Neutral | Get Alert |
| 04/12/2022 | Buy Now | -44.53% | Morgan Stanley | Ricky Goldwasser78% | → $74 | Upgrade | Equal-Weight → Overweight | Get Alert |
FAQ
What is the target price for Cardinal Health (CAH) stock?
The latest price target for Cardinal Health (NYSE:CAH) was reported by Jefferies on February 5, 2025. The analyst firm set a price target for $150.00 expecting CAH to rise to within 12 months (a possible 12.43% upside). 34 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cardinal Health (CAH)?
The latest analyst rating for Cardinal Health (NYSE:CAH) was provided by Jefferies, and Cardinal Health upgraded their buy rating.
When was the last upgrade for Cardinal Health (CAH)?
The last upgrade for Cardinal Health Inc happened on February 5, 2025 when Jefferies raised their price target to $150. Jefferies previously had a hold for Cardinal Health Inc.
When was the last downgrade for Cardinal Health (CAH)?
The last downgrade for Cardinal Health Inc happened on July 10, 2023 when Evercore ISI Group changed their price target from N/A to $100 for Cardinal Health Inc.
When is the next analyst rating going to be posted or updated for Cardinal Health (CAH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardinal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardinal Health was filed on February 5, 2025 so you should expect the next rating to be made available sometime around February 5, 2026.
Is the Analyst Rating Cardinal Health (CAH) correct?
While ratings are subjective and will change, the latest Cardinal Health (CAH) rating was a upgraded with a price target of $140.00 to $150.00. The current price Cardinal Health (CAH) is trading at is $133.42, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.